CN115605608A - 帕金森氏病的检测方法 - Google Patents

帕金森氏病的检测方法 Download PDF

Info

Publication number
CN115605608A
CN115605608A CN202180035027.2A CN202180035027A CN115605608A CN 115605608 A CN115605608 A CN 115605608A CN 202180035027 A CN202180035027 A CN 202180035027A CN 115605608 A CN115605608 A CN 115605608A
Authority
CN
China
Prior art keywords
test
gene
expression
disease
parkinson
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180035027.2A
Other languages
English (en)
Chinese (zh)
Inventor
上原裕也
井上高良
服部信孝
齐木臣二
上野真一
竹重遥香
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Saitama Medical University
Original Assignee
Kao Corp
Saitama Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp, Saitama Medical University filed Critical Kao Corp
Publication of CN115605608A publication Critical patent/CN115605608A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2835—Movement disorders, e.g. Parkinson, Huntington, Tourette

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CN202180035027.2A 2020-05-14 2021-05-14 帕金森氏病的检测方法 Pending CN115605608A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020085430 2020-05-14
JP2020-085430 2020-05-14
PCT/JP2021/018511 WO2021230379A1 (ja) 2020-05-14 2021-05-14 パーキンソン病の検出方法

Publications (1)

Publication Number Publication Date
CN115605608A true CN115605608A (zh) 2023-01-13

Family

ID=78525192

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180035027.2A Pending CN115605608A (zh) 2020-05-14 2021-05-14 帕金森氏病的检测方法

Country Status (5)

Country Link
US (1) US20230183806A1 (https=)
EP (1) EP4151752A4 (https=)
JP (1) JP7849812B2 (https=)
CN (1) CN115605608A (https=)
WO (1) WO2021230379A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025113506A1 (zh) * 2023-12-01 2025-06-05 上海市东方医院（同济大学附属东方医院） 诊断和治疗阿尔茨海默病的医药制剂

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115803450A (zh) * 2020-07-10 2023-03-14 花王株式会社 特应性皮炎的重症度的检测方法
KR20240143936A (ko) * 2023-03-21 2024-10-02 주식회사 키베이직 콧물 시료를 이용한 반려동물의 인지 장애 진단용 조성물
CN117051102B (zh) * 2023-10-12 2024-01-26 上海爱谱蒂康生物科技有限公司 生物标志物组合在制备预测帕金森病的产品中的应用
JP2025170775A (ja) * 2024-05-07 2025-11-19 花王株式会社 情報処理装置

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060097224A (ko) * 2005-03-04 2006-09-14 한국생명공학연구원 파킨슨병 유전자 마커 및 이를 이용한 파킨슨병 진단킷트
CN109337975A (zh) * 2018-12-24 2019-02-15 潘伟 基因标志物在帕金森诊断中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6565010B2 (ja) 2014-10-09 2019-08-28 有限会社ピコデバイス パーキンソン病の早期診断方法
EP3411500B9 (en) 2016-02-05 2023-10-04 St. John's University Circulating serum microrna biomarkers and methods for determining parkinson's disease
EP3372693B1 (en) 2016-07-08 2020-02-12 Kao Corporation Method for preparing nucleic acid sample
GB201812561D0 (en) 2018-08-01 2018-09-12 Univ Manchester Biomarkers and uses thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060097224A (ko) * 2005-03-04 2006-09-14 한국생명공학연구원 파킨슨병 유전자 마커 및 이를 이용한 파킨슨병 진단킷트
CN109337975A (zh) * 2018-12-24 2019-02-15 潘伟 基因标志物在帕金森诊断中的应用

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025113506A1 (zh) * 2023-12-01 2025-06-05 上海市东方医院（同济大学附属东方医院） 诊断和治疗阿尔茨海默病的医药制剂

Also Published As

Publication number Publication date
EP4151752A4 (en) 2025-08-13
US20230183806A1 (en) 2023-06-15
EP4151752A1 (en) 2023-03-22
JP2021180654A (ja) 2021-11-25
JP7849812B2 (ja) 2026-04-22
WO2021230379A1 (ja) 2021-11-18

Similar Documents

Publication Publication Date Title
CN115605608A (zh) 帕金森氏病的检测方法
EP2909340B1 (en) Diagnostic method for predicting response to tnf alpha inhibitor
US20140128277A1 (en) Method for Identifying a Subset of Polynucleotides from an Initial Set of Polynucleotides Corresponding to the Human Genome for the In Vitro Determination of the Severity of the Host Response of a Patient
JP2016526888A (ja) 敗血症バイオマーカー及びそれらの使用
US20240309469A1 (en) Methods to detect and treat a fungal infection
JP7743217B2 (ja) アトピー性皮膚炎の重症度の検出方法
JP2022049694A (ja) 乳幼児アトピー性皮膚炎の検出方法
JP7743475B2 (ja) アトピー性皮膚炎の検出方法
EP4189117B1 (en) Use of circular rna for the diagnosis of multiple sclerosis
JP7743474B2 (ja) 乳幼児アトピー性皮膚炎の検出方法
JP7767500B2 (ja) アトピー性皮膚炎の重症度の検出方法
KR20200039654A (ko) 신장이식 환자의 급성거부반응 진단용 소변 전사체 및 이의 용도
JP7847451B2 (ja) アトピー性皮膚炎による皮膚痒みの症度悪化の検出方法
JP7847450B2 (ja) アトピー性皮膚炎の症度悪化の検出方法
JP7750481B2 (ja) 内臓脂肪面積の検出方法
WO2025088149A1 (en) Novel biomarkers for prognosis of community acquired pneumonia (cap)
EP4584399A1 (en) Methods to predict response to icbt of a patient having cancer
US20250298015A1 (en) Diagnostic method of detecting inflammation biomarker(s)
JP2023048811A (ja) 疲労の検出方法
JP2023048810A (ja) 慢性ストレスレベルの検出方法
JP2023073134A (ja) ホットフラッシュの検出方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination